These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 36288392)
1. Understanding a high-risk acute myeloid leukemia by analyzing the interactome of its major driver mutation. Chiriches C; Nicolaisen N; Wieske M; Elhaddad H; Mehmetbeyoglu E; Alvares C; Becher D; Hole P; Ottmann OG; Ruthardt M PLoS Genet; 2022 Oct; 18(10):e1010463. PubMed ID: 36288392 [TBL] [Abstract][Full Text] [Related]
2. Panagopoulos I; Gorunova L; Torkildsen S; Tjønnfjord GE; Micci F; Heim S Cancer Genomics Proteomics; 2017; 14(6):437-443. PubMed ID: 29109093 [TBL] [Abstract][Full Text] [Related]
3. Myelodysplastic syndrome with t(6;9)(p22;q34.1)/DEK-NUP214 better classified as acute myeloid leukemia? A multicenter study of 107 cases. Fang H; Yabe M; Zhang X; Kim Y; Wu X; Wei P; Chi S; Zheng L; Garcia-Manero G; Shao L; Yuan J; Shen Y; Zheng G; Tang G; Wang W; Loghavi S; Shen Q; Yuan Y; He R; Chen D; Medeiros LJ; Hu S Mod Pathol; 2021 Jun; 34(6):1143-1152. PubMed ID: 33558656 [TBL] [Abstract][Full Text] [Related]
4. Forced expression of the DEK-NUP214 fusion protein promotes proliferation dependent on upregulation of mTOR. Sandén C; Ageberg M; Petersson J; Lennartsson A; Gullberg U BMC Cancer; 2013 Sep; 13():440. PubMed ID: 24073922 [TBL] [Abstract][Full Text] [Related]
5. [Analysis of 7 cases of pediatric acute myeloid leukemia with DEK-NUP214 fusion gene]. Li XL; Liu LP; Wan Y; Liu F; Chen X; Ren YY; Ruan M; Guo Y; Zhu XF; Yang WY Zhonghua Er Ke Za Zhi; 2023 Apr; 61(4):357-362. PubMed ID: 37011983 [No Abstract] [Full Text] [Related]
6. Activation of signaling pathways in models of t(6;9)-acute myeloid leukemia. Chiriches C; Khan D; Wieske M; Guillen N; Rokicki M; Guy C; Wilson M; Heesom KJ; Ottmann OG; Ruthardt M Ann Hematol; 2022 Oct; 101(10):2179-2193. PubMed ID: 35941390 [TBL] [Abstract][Full Text] [Related]
7. [Prognostic significance of DEK-NUP214 fusion gene in patients with acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation]. Gao MG; Fu Q; Qin YZ; Chang YJ; Wang Y; Yan CH; Xu LP; Zhang XH; Huang XJ; Zhao XS Zhonghua Nei Ke Za Zhi; 2021 Oct; 60(10):868-874. PubMed ID: 34551474 [No Abstract] [Full Text] [Related]
8. The DEK oncoprotein and its emerging roles in gene regulation. Sandén C; Gullberg U Leukemia; 2015 Aug; 29(8):1632-6. PubMed ID: 25765544 [TBL] [Abstract][Full Text] [Related]
9. Transformation of human CD34+ hematopoietic progenitor cells with DEK-NUP214 induces AML in an immunocompromised mouse model. Qin H; Malek S; Cowell JK; Ren M Oncogene; 2016 Oct; 35(43):5686-5691. PubMed ID: 27065320 [TBL] [Abstract][Full Text] [Related]
10. t(6;9)(p22;q34)/DEK-NUP214-rearranged pediatric myeloid leukemia: an international study of 62 patients. Sandahl JD; Coenen EA; Forestier E; Harbott J; Johansson B; Kerndrup G; Adachi S; Auvrignon A; Beverloo HB; Cayuela JM; Chilton L; Fornerod M; de Haas V; Harrison CJ; Inaba H; Kaspers GJ; Liang DC; Locatelli F; Masetti R; Perot C; Raimondi SC; Reinhardt K; Tomizawa D; von Neuhoff N; Zecca M; Zwaan CM; van den Heuvel-Eibrink MM; Hasle H Haematologica; 2014 May; 99(5):865-72. PubMed ID: 24441146 [TBL] [Abstract][Full Text] [Related]
12. STAT activation status differentiates leukemogenic from non-leukemogenic stem cells in AML and is suppressed by arsenic in t(6;9)-positive AML. Oancea C; Rüster B; Brill B; Roos J; Heinssmann M; Bug G; Mian AA; Guillen NA; Kornblau SM; Henschler R; Ruthardt M Genes Cancer; 2014 Nov; 5(11-12):378-92. PubMed ID: 25568664 [TBL] [Abstract][Full Text] [Related]
13. DEK oncogene expression during normal hematopoiesis and in Acute Myeloid Leukemia (AML). Logan GE; Mor-Vaknin N; Braunschweig T; Jost E; Schmidt PV; Markovitz DM; Mills KI; Kappes F; Percy MJ Blood Cells Mol Dis; 2015 Jan; 54(1):123-31. PubMed ID: 25128083 [TBL] [Abstract][Full Text] [Related]
14. Identification of a novel and myeloid specific role of the leukemia-associated fusion protein DEK-NUP214 leading to increased protein synthesis. Ageberg M; Drott K; Olofsson T; Gullberg U; Lindmark A Genes Chromosomes Cancer; 2008 Apr; 47(4):276-87. PubMed ID: 18181180 [TBL] [Abstract][Full Text] [Related]
15. Role of the DEK oncogene in the development of squamous cell carcinoma. Ishida K; Nakashima T; Shibata T; Hara A; Tomita H Int J Clin Oncol; 2020 Sep; 25(9):1563-1569. PubMed ID: 32656741 [TBL] [Abstract][Full Text] [Related]
16. Identification of a novel fusion TBL1XR1-PDGFRB in a patient with acute myeloid leukemia harboring the DEK-NUP214 fusion and clinical response to dasatinib. Campregher PV; Halley NDS; Vieira GA; Fernandes JF; Velloso EDRP; Ali S; Mughal T; Miller V; Mangueira CLP; Odone V; Hamerschlak N Leuk Lymphoma; 2017 Dec; 58(12):2969-2972. PubMed ID: 28509585 [No Abstract] [Full Text] [Related]
17. Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK-NUP214 shows a favourable outcome when performed in first complete remission. Díaz-Beyá M; Labopin M; Maertens J; Aljurf M; Passweg J; Dietrich B; Schouten H; Socié G; Schaap N; Schwerdtfeger R; Volin L; Michallet M; Polge E; Sierra J; Mohty M; Esteve J; Nagler A; Br J Haematol; 2020 Jun; 189(5):920-925. PubMed ID: 32020596 [TBL] [Abstract][Full Text] [Related]
18. The impact of the chromatin binding DEK protein in hematopoiesis and acute myeloid leukemia. Wilcher KE; Page ERH; Privette Vinnedge LM Exp Hematol; 2023 Jul; 123():18-27. PubMed ID: 37172756 [TBL] [Abstract][Full Text] [Related]
19. [Analysis of therapeutic effects of allogeneic hematopoietic stem cell transplantation in 12 patients with DEK-NUP214 fusion gene positive acute myeloid leukemia]. Shen YY; Yang DL; He Y; Pang AM; Chen X; Ma QL; Zhang RL; Wei JL; Zhai WH; Han MZ; Jiang EL; Feng SZ Zhonghua Xue Ye Xue Za Zhi; 2024 Apr; 45(4):383-387. PubMed ID: 38951067 [TBL] [Abstract][Full Text] [Related]
20. Chromatin redistribution of the DEK oncoprotein represses hTERT transcription in leukemias. Karam M; Thenoz M; Capraro V; Robin JP; Pinatel C; Lancon A; Galia P; Sibon D; Thomas X; Ducastelle-Lepretre S; Nicolini F; El-Hamri M; Chelghoun Y; Wattel E; Mortreux F Neoplasia; 2014 Jan; 16(1):21-30. PubMed ID: 24563617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]